Comparing blood thinners and treatment length after a heart attack
Treatments studied
Part of Heart & circulation clinical trials.
This trial compares two common blood-thinning medications (prasugrel vs ticagrelor) and two treatment durations (short 1–3 months vs standard 12 months) after a heart attack treated with stents. It aims to find the most effective and safest anti-clotting strategy for patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You had a heart attack (with or without ST-elevation) and were treated with a stent
- You do not need blood thinners for other reasons (like a heart valve problem or blood clots)
- You have not had a stroke or transient ischemic attack (TIA) in the past
- You are not pregnant or breastfeeding
- You have no active bleeding or a bleeding disorder
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether patients with both irregular heartbeat (atrial fibrillation) and a recent heart attack can safely take a shorter course of blood-thinning medications after a stent procedure. The goal is to reduce bleeding risk while still protecting against future clots.
This trial compares taking a shorter course of prasugrel (a blood thinner) plus aspirin after a heart attack versus the standard 12-month course. It aims to see if a shorter duration is just as effective and safer for people who got a specific type of stent (everolimus-eluting).
This trial compares two ways of using anti-platelet (blood-thinner) medicines after a specific kind of heart attack (STEMI) treated with a stent. It aims to see if switching sooner to one medicine (instead of two for longer) works just as well and may reduce risks.
This trial tests if people who have been on two blood thinners (aspirin plus prasugrel or ticagrelor) for at least 90 days after getting a heart stent can safely switch to just one of those blood thinners. It aims to see if taking only one pill is as safe and effective as taking two.
This study tests whether taking a single blood-thinning medication (instead of two) after heart stent placement is safe and effective over the long term. If you've recovered well from a stent procedure, this trial may help determine the safest way to prevent future heart problems.
This study compares two ways to manage blood thinners after a stent. It tests whether switching from stronger drugs (prasugrel or ticagrelor) to clopidogrel is safe and effective for long-term heart protection.
Hear when a new Myocardial Infarction (MI) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.